122 related articles for article (PubMed ID: 6206382)
21. Induction chemotherapy with methotrexate, bleomycin and hydroxyurea with or without cisplatin in advanced squamous cell carcinoma of the head and neck: a study of the Swiss Group for Clinical Cancer Research (SAKK).
Abele R; Honegger HP; Wolfensberger M; Grossenbacher R; Mermillod B; Cavalli F
Prog Clin Biol Res; 1985; 201():169-75. PubMed ID: 2419916
[No Abstract] [Full Text] [Related]
22. Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.
Vogl SE; Komisar A; Kaplan BH; Engstrom PF; Kasule OH; Stolbach L; Lerner H; Muggia F
Cancer; 1986 Feb; 57(4):706-10. PubMed ID: 2417680
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
[TBL] [Abstract][Full Text] [Related]
24. [Combined chemotherapy for head and neck cancer using cisplatin, methotrexate and continuous subcutaneous infusion of peplomycin].
Kagami Y; Nishio M; Saitoh A; Doi Y; Asano K; Sakurai T; Murakami Y; Narimatsu N
Gan To Kagaku Ryoho; 1985 Feb; 12(2):337-42. PubMed ID: 2578770
[TBL] [Abstract][Full Text] [Related]
25. Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck.
Fountzilas G; Nicolaou A; Sridhar K; Sideras T; Haritanti A; Anastasakis C; Delis V; Vritsios A; Daniilidis J
Arch Otorhinolaryngol; 1989; 246(5):373-7. PubMed ID: 2480104
[TBL] [Abstract][Full Text] [Related]
26. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
27. A nontoxic adjuvant treatment for advanced head and neck cancer.
Spaulding MB; Vasquez J; Khan A; Sundquist N; Lorè JM
Arch Otolaryngol; 1983 Dec; 109(12):789-91. PubMed ID: 6685474
[TBL] [Abstract][Full Text] [Related]
28. [Polychemotherapy using platidiam in disseminated squamous cell cancer of the head and neck].
Mishin IuB
Vopr Onkol; 1988; 34(2):162-6. PubMed ID: 2450425
[TBL] [Abstract][Full Text] [Related]
29. Induction therapy in head and neck cancer. A comparison of two regimens.
Spaulding M; Ziegler P; Sundquist N; Klotch D; Lee K; Khan A; Lore J
Cancer; 1986 Mar; 57(6):1110-4. PubMed ID: 2417692
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin plus vinorelbine for patients with advanced head and neck squamous cell carcinoma.
Segura A; Pastor M; Santaballa A; Yuste A; López P; Aparicio J
Oncologist; 2000; 5(2):177-8. PubMed ID: 10794811
[No Abstract] [Full Text] [Related]
31. Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck.
Gebbia V; Testa A; Di Gregorio C; Ingria F; Valenza R; Cannata G; Moschella F; Restivo G; Gebbia N
Am J Clin Oncol; 1995 Aug; 18(4):293-6. PubMed ID: 7625368
[TBL] [Abstract][Full Text] [Related]
32. [Induction chemotherapy with cisplatin and peplomycin in squamous cell carcinoma of the head and neck].
Takagi T; Sakai C; Oguro M; Omura K; Shimada H; Takemiya S; Kuwahara T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):543-6. PubMed ID: 2434031
[No Abstract] [Full Text] [Related]
33. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
Abele R; Honegger HP; Grossenbacher R; Mermillod B; Kaplan E; Gervasi A; Wolfensberger M; Lehmann W; Cavalli F
Eur J Cancer Clin Oncol; 1987 Jan; 23(1):47-53. PubMed ID: 2439344
[TBL] [Abstract][Full Text] [Related]
34. [Effect of the combination of cisplatin and peplomycin on Ehrlich ascites carcinoma and on head and neck squamous cell carcinoma transplanted to nude mice].
Mashino S
Nihon Jibiinkoka Gakkai Kaiho; 1985 Apr; 88(4):502-11. PubMed ID: 2411898
[No Abstract] [Full Text] [Related]
35. 5-fluorouracil + folinic acid with cisplatinum and bleomycin in the treatment of advanced head and neck squamous cell carcinoma.
Guaraldi M; Martoni A; Tononi A; Occhiuzzi L; Caliceti U; Dall'Olio D; Laudadio P; Pannuti F
Ann Oncol; 1991 May; 2(5):379-81. PubMed ID: 1720018
[TBL] [Abstract][Full Text] [Related]
36. Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial.
Morton RP; Rugman F; Dorman EB; Stoney PJ; Wilson JA; McCormick M; Veevers A; Stell PM
Cancer Chemother Pharmacol; 1985; 15(3):283-9. PubMed ID: 2414023
[TBL] [Abstract][Full Text] [Related]
37. Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.
Haines I; Bosl G; Pfister D; Spiro R; Gerold F; Sessions R; Shah J; Strong E; Vikram B; Harrison L
J Clin Oncol; 1987 Oct; 5(10):1594-600. PubMed ID: 2443621
[TBL] [Abstract][Full Text] [Related]
38. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
Clavel M; Vermorken JB; Cognetti F; Cappelaere P; de Mulder PH; Schornagel JH; Tueni EA; Verweij J; Wildiers J; Clerico M
Ann Oncol; 1994 Jul; 5(6):521-6. PubMed ID: 7522527
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
Sridhar KS; Ohnuma T; Biller H; Holland JF; Ambinder EP; Barba J
Am J Clin Oncol; 1985 Feb; 8(1):55-60. PubMed ID: 2581436
[TBL] [Abstract][Full Text] [Related]
40. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
Ervin TJ; Weichselbaum R; Miller D; Meshad M; Posner M; Fabian R
Cancer Treat Rep; 1981; 65(9-10):787-91. PubMed ID: 6168371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
